Concentrat de proteine din zer (WPC) Proteine izolate din zer (WPI) Hidrolizat de proteine din zer (WPH) Proteine vegetale Cazein Protein Citrulin Arginin Rezumat L-carnitina este forma biologic activ de carnitin utilizat de organism
A dual GIP and GLP-1 receptor agonist developed by Eli Lilly, Tirzepatide, has demonstrated weight loss results up to 22.5% in diabetes and obesity management
Austin, United States, May 26, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the global GLP-1 Receptor Agonist Market was valued at USD 60.6 Billion in 2025 and is expected to reach USD 307 Billion by 2035, growing at a CAGR of 17.61% from 20262035. The GLP-1 Receptor Agonist Market has experienced an unprecedented growth trend due to the increasing rate of diabetes and obesity cases around the world and the rising need for long-term metabolic diseases treatment solutions
Raw data for statistical analyses and supplemental data are available at Zenodo (DOI: 10.5281/zenodo.14916225) Ethics statement The animal study was approved by Lower Saxony State Office for Consumer Protection and Food Safety (LAVES, Oldenburg, Germany)
